RT Journal
A1 Scott J
T1 ANtabus® for alcoholism
JF Journal of the American Medical Association
JO Journal of the American Medical Association
YR 1949
FD April 2
VO 139
IS 14
SP 954
OP 954
DO 10.1001/jama.1949.02900310058022
UL http://dx.doi.org/10.1001/jama.1949.02900310058022
AB To the Editor:— 
    As you know, a new approach to the medical management of alcoholism was recently reported in the Scandinavian as well as the British literature (Acta pharmacol. et toxicol. 4:285-321 [Dec.] 1948; Lancet2: 1001 [Dec. 25] 1948). The substance used was antabus,® a highly purified brand of tetraethylthiuramdisulfide specially prepared by Medicinalco, Copenhagen, Denmark. Antabus® is capable of producing pronounced physical discomfort when it is taken prior to the ingestion of alcohol and tends to create in the alcoholic patient a disinclination to drink. On this basis, its value as an adjunct to recognized psychotherapeutic measures has been suggested (Lancet2: 1004 [Dec. 25] 1948).Because of the sociologic significance of this development, widespread interest has been aroused by the publicity which antabus® has received in the United States. This letter is sent to you with the thought that it may provide a means of informing